Filing metadata

Accession number
0000899243-22-003861
Form type
Form 3
Filer
Checkmate Pharmaceuticals, Inc.
CIK
CIK 1651431
Filed
Feb 01, 2022
Reporting period
Jan 30, 2022
Description
Initial ownership

Explore SEC Filings Hub